Trials / Unknown
UnknownNCT04178135
Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Reproductive & Genetic Hospital of CITIC-Xiangya · Academic / Other
- Sex
- Female
- Age
- 35 Months – 40 Years
- Healthy volunteers
- Accepted
Summary
A randomized, controlled, pilot study, for Patients ≥ 35 years and \< 40 years old with sufficient ovarian reserve parameters (AFC≥ 5), but showed an unexpected poor or suboptimal ovarian response(defined as ≤ 9 retrieved oocytes in previous full-stimulation cycle, but not get live birth after all embryos were used ). In order to get better oocyte number and quality in the new COS cycle, we will compare LH supplementation from beginning with from middle of stimulation in GnRH-a long protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rLH | rLH supplement from day 1 of stimulation |
| DRUG | rLH | rLH supplement from day 6 of stimulation |
Timeline
- Start date
- 2019-12-25
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
- First posted
- 2019-11-26
- Last updated
- 2022-01-11
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04178135. Inclusion in this directory is not an endorsement.